Document Type
Original Article
Abstract
Background: The outbreak of Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has put immense pressure on healthcare systems in many countries. Vague models that explain the pathophysiology for SARS-CoV-2 exist. There has been many multiorgan symptoms attributed to it including dermatological manifestations, early on in the pandemic first phase skin symptoms were not documented but lately reports of cutaneous manifestations of convid-12 has begun to surface.
Aim of the study: to evaluate and find out the prevalence of the dermatologic manifestations in patients with COVID-19 and identify specific lesions that may facilitate diagnosis.
Patients and methods: This cross-sectional study was carried out in Dermatology, Venereology and Andrology department, Faculty of Medicine – Al-Azhar University, on 1000 patients confirmed as infected by COVID-19 by nasopharyngeal PCR. They were recruited from the isolation hospitals in Alexandria and Al-Beheira governorates through weekly visits, from May to October 2021.
Result: There was statistically significant relation between severity of COVID-19 and rash type (p= 0.034). It was noticed that vasculitis was significantly higher in severe cases. Other types of rash were common in moderate cases.
Conclusion: In conclusion, we provide a description of the cutaneous manifestations associated with COVID-19. These may help clinicians approach patients with the disease and recognize cases with few symptoms.
Keywords
COVID-19; SARS-CoV-2; cutaneous manifestations
Subject Area
Dermatology
How to Cite This Article
Abokhalil, Abdelrahman Mohamed Helmi; Elmohamady, Abdelshakour Abdelhafiz; and Mohamed, Osama Khalil Elsayed
(2023)
"Prevalence of Clinical Cutaneous Manifestations in Confirmed COVID-19 Patients,"
Al-Azhar International Medical Journal: Vol. 4:
Iss.
9, Article 12.
DOI: https://doi.org/10.58675/2682-339X.2035
